No black box warning on record for Acamprosate Calcium

As of the latest FDA labeling reviewed, Acamprosate Calcium (ACAMPROSATE CALCIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Acamprosate Calcium medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Dose reduction is required for patients with moderate renal impairment ( 5.1 ). Monitor patients for depression or suicidal ideation and prompt patients, families, and caregivers to report such symptoms to the health care provider ( 5.2 ). 5.1 Renal Impairment Treatment with acamprosate calcium in patients with moderate renal impairment (creatinine clearance of 30 to 50

No black box warning on record for Acamprosate Calcium

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Dose reduction is required for patients with moderate renal impairment ( 5.1 ). Monitor patients for depression or suicidal ideation and prompt patients, families, and caregivers to report such symptoms to the health care provider ( 5.2 ). 5.1 Renal Impairment Treatment with acamprosate calcium in patients with moderate renal impairment (creatinine clearance of 30 to 50

Acamprosate Calcium Black Box Warning

No black box warning on record for Acamprosate Calcium

Other warnings & precautions

Acamprosate Calcium Black Box Warning

No black box warning on record for Acamprosate Calcium

Other warnings & precautions